Melis McHenry

Melis McHenry

Company: Regeneron

Job title: Associate Director, Precision Medicine CDx


Considerations for Strategy, Regulatory Requirements, Implementation & Commercialization of a NASH CDx Assay 11:30 am

The global prevalence of Nonalcoholic steatohepatitis, or NASH, is increasing with over 5% of the general population affected. If untreated, NASH may progress to liver cirrhosis, liver carcinoma, and death Numerous risk factors influence the development of NASH, including genetic predisposition. We initiated an investigational trial for a hepatocyte-targeted siRNA approach in NASH A clinical…Read more

day: Day 1 Track C AM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.